Renal Involvement in Systemic Amyloidosis Caused by Monoclonal Immunoglobulins.
Sign Up to like & getrecommendations! Published in 2020 at "Hematology/oncology clinics of North America"
DOI: 10.1016/j.hoc.2020.08.002
Abstract: Kidney involvement in immunoglobulin-related amyloidosis (AIg) is common. Although patients with renal-limited AIg tend not to have the high mortality that patients with cardiac amyloidosis have, they do experience significant morbidity and impact on quality… read more here.
Keywords: involvement systemic; amyloidosis caused; caused monoclonal; systemic amyloidosis ... See more keywords
Systemic Amyloidosis Caused by Monoclonal Immunoglobulins: Soft Tissue and Vascular Involvement.
Sign Up to like & getrecommendations! Published in 2020 at "Hematology/oncology clinics of North America"
DOI: 10.1016/j.hoc.2020.08.004
Abstract: Clinical features of soft tissue amyloid light-chain (AL) amyloidosis include macroglossia, arthropathy, muscle pseudohypertrophy, skin plaques, and carpal tunnel syndrome. Vascular manifestations of AL amyloid include periorbital ecchymosis, jaw or limb claudication, and even myocardial… read more here.
Keywords: soft tissue; amyloidosis caused; caused monoclonal; amyloidosis ... See more keywords
Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis
Sign Up to like & getrecommendations! Published in 2018 at "Haematologica"
DOI: 10.3324/haematol.2018.203000
Abstract: Amyloidoses are a group of heterogeneous diseases caused by the extracellular deposition of insoluble proteins or peptides in a beta-pleated sheet pattern.[1][1]–[4][2] There are approximately 30 different proteins that are known to produce the disease… read more here.
Keywords: caused peptide; peptide drug; amyloidosis caused; novel iatrogenic ... See more keywords